Cryo-Cell International (FRA:ZCY) LT-Debt-to-Total-Asset: 0.14 (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:ZCY Cryo-Cell International Inc FRA:ZCY
65 GF Score
Price €2.82
GF Value €4.73
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Cryo-Cell International LT-Debt-to-Total-Asset?

Cryo-Cell International FRA:ZCY +2.17% 65 LT-Debt-to-Total-Asset is 0.14 as of Feb. 2026. GuruFocus rates FRA:ZCY with a GF Score™ of 65/100 and a GF Value™ of €4.73 (Possible Value Trap). The stock has 4 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Cryo-Cell International's long-term debt to total assests ratio for the quarter that ended in Feb. 2026 was 0.14.

Cryo-Cell International's long-term debt to total assets ratio increased from Feb. 2025 (0.14) to Feb. 2026 (0.14). It may suggest that Cryo-Cell International is progressively becoming more dependent on debt to grow their business.

Cryo-Cell International  (FRA:ZCY) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Cryo-Cell International LT-Debt-to-Total-Asset Related Terms

Cryo-Cell International LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Cryo-Cell International's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cryo-Cell International LT-Debt-to-Total-Asset Chart

Cryo-Cell International Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.14 0.15 0.14 0.14

Cryo-Cell International Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.13 0.14 0.14 0.14
FRA:ZCY
65GF Score
Cryo-Cell International Inc FRA:ZCY
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cryo-Cell International LT-Debt-to-Total-Asset Calculation

Cryo-Cell International's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Nov. 2025 is calculated as

LT Debt to Total Assets (A: Nov. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Nov. 2025 )/Total Assets (A: Nov. 2025 )
=7.478/53.396
=0.14

Cryo-Cell International's Long-Term Debt to Total Asset Ratio for the quarter that ended in Feb. 2026 is calculated as

LT Debt to Total Assets (Q: Feb. 2026 )=Long-Term Debt & Capital Lease Obligation (Q: Feb. 2026 )/Total Assets (Q: Feb. 2026 )
=7.188/51.509
=0.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.14 mean?
Cryo-Cell International (FRA:ZCY) has a LT-Debt-to-Total-Asset of 0.14 as of Feb. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Cryo-Cell International and its competitors.
Is Cryo-Cell International's LT-Debt-to-Total-Asset too high?
Cryo-Cell International's current LT-Debt-to-Total-Asset is 0.14. Overall, Cryo-Cell International has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cryo-Cell International's LT-Debt-to-Total-Asset compare to CCM and CDIX?
Cryo-Cell International's LT-Debt-to-Total-Asset of 0.14 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Healthcare Providers & Services company?
A good LT-Debt-to-Total-Asset depends on the Healthcare Providers & Services industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Cryo-Cell International and its competitors. Cryo-Cell International's current LT-Debt-to-Total-Asset is 0.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cryo-Cell International stock overvalued right now?
Based on GuruFocus' analysis, Cryo-Cell International (FRA:ZCY) is currently considered Possible Value Trap. The stock's GF Value™ is €4.73, compared to a current price of €2.82 — trading 40.4% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.14. Cryo-Cell International's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Cryo-Cell International (FRA:ZCY), the current LT-Debt-to-Total-Asset is 0.14 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cryo-Cell International (FRA:ZCY) Overvalued in 2026?

Based on GuruFocus' analysis, Cryo-Cell International stock appears to be undervalued. The current stock price of €2.82 is trading 40.4% below its estimated GF Value™ of €4.73. GuruFocus considers Cryo-Cell International to be Possible Value Trap.

Key valuation signals for FRA:ZCY:

  • LT-Debt-to-Total-Asset: 0.14
  • GF Value™: €4.73 vs. price of €2.82 (40.4% below fair value)
  • GF Score™: 65/100 with 4 warning signs

No single metric tells the full story. See the FRA:ZCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cryo-Cell International Business Description

Other Exchanges CCEL:USA
Address 700 Brooker Creek Boulevard, Suite 1800, Oldsmar, FL, USA, 34677
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
65GF Score

Get the complete analysis for FRA:ZCY

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.82
Price
€4.73
GF Value